Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:1643-1646

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitchel, J.
Right arrow Articles by Heller, G. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchel, J.
Right arrow Articles by Heller, G. V.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Acute coronary syndromes

(Circulation. 2000;101:1643.)
© 2000 American Heart Association, Inc.


Brief Rapid Communications

Identification of Coronary Thrombus With a IIb/IIIa Platelet Inhibitor Radiopharmaceutical, Technetium-99m DMP-444

A Canine Model

Joseph Mitchel, DO; David Waters, MD; Tianjie Lai, MD; Michael White, CNMT; Tod Alberghini, BS; Ahmad Salloum, MD; David Knibbs, PhD; Dadong Li, MD; Gary V. Heller, MD, PhD

From the Nuclear Cardiology and Cardiac Catheterization Laboratories, Division of Cardiology, Hartford Hospital, Hartford, Conn, and the University of Connecticut School of Medicine, Farmington, Conn.

Correspondence to Joseph Mitchel, DO, Cardiac Catheterization Laboratory, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102-5037. E-mail: Jmitche{at}harthosp.org

Background—A diagnostic test that could distinguish between stable and unstable coronary atherosclerotic plaques would be useful. We tested the ability of a new glycoprotein IIb/IIIa platelet inhibitor DMP-444, labeled with technetium (Tc)-99 m, to identify platelet-rich thrombus by nuclear imaging in a canine model.

Methods and Results—Combinations of a flow-limiting stenosis and 0 to 15 minutes of endothelial electrical stimulation at a site in the left anterior descending coronary artery were used to induce varying amounts of thrombus formation. In 10 animals with markedly positive nuclear images after the injection of Tc-99m DMP-444, the presence of platelet-rich thrombus was confirmed postmortem by gross appearance, high nuclear counts, and abundant platelets on electron microscopy. The 10 animals with negative images had lower counts, smaller thrombus weights (P<0.05 for each), and fewer platelets by electron microscopy.

Conclusions—Activated platelets participating in acute thrombus formation can be accurately detected by nuclear imaging using Tc-99 m DMP-444.


Key Words: diagnosis • imaging • platelet aggregation inhibitors • thrombosis




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
H. F. Langer, R. Haubner, B. J. Pichler, and M. Gawaz
Radionuclide imaging a molecular key to the atherosclerotic plaque.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Sakuma, I. Sari, C. N. Goodman, J. R. Lindner, A. L. Klibanov, and S. Kaul
Simultaneous integrin {alpha}v{beta}3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty
Cardiovasc Res, June 1, 2005; 66(3): 552 - 561.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. R. Davies, J. H. Rudd, and P. L. Weissberg
Molecular and Metabolic Imaging of Atherosclerosis
J. Nucl. Med., November 1, 2004; 45(11): 1898 - 1907.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Sakuma, J. Sklenar, H. Leong-Poi, N. C. Goodman, D. K. Glover, and S. Kaul
Molecular Imaging Identifies Regions with Microthromboemboli During Primary Angioplasty in Acute Coronary Thrombosis
J. Nucl. Med., July 1, 2004; 45(7): 1194 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. D. MacNeill, H. C. Lowe, M. Takano, V. Fuster, and I.-K. Jang
Intravascular Modalities for Detection of Vulnerable Plaque: Current Status
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1333 - 1342.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Chen, C.-H. Tung, U. Mahmood, V. Ntziachristos, R. Gyurko, M. C. Fishman, P. L. Huang, and R. Weissleder
In Vivo Imaging of Proteolytic Activity in Atherosclerosis
Circulation, June 11, 2002; 105(23): 2766 - 2771.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P J de Feyter and K Nieman
New coronary imaging techniques: what to expect?
Heart, March 1, 2002; 87(3): 195 - 197.
[Full Text] [PDF]


Home page
Circ. Res.Home page
Z. A. Fayad and V. Fuster
Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque
Circ. Res., August 17, 2001; 89(4): 305 - 316.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Ohtsuki, M. Hayase, K. Akashi, S. Kopiwoda, and H. W. Strauss
Detection of Monocyte Chemoattractant Protein-1 Receptor Expression in Experimental Atherosclerotic Lesions: An Autoradiographic Study
Circulation, July 10, 2001; 104(2): 203 - 208.
[Abstract] [Full Text] [PDF]